Department of General Practice, Amsterdam UMC, University of Amsterdam, Amsterdam, Netherlands; Department of Public and Occupational Health, Amsterdam UMC, University of Amsterdam, Amsterdam, Netherlands.
Department of General Practice, Amsterdam UMC, University of Amsterdam, Amsterdam, Netherlands; Department of Public and Occupational Health, Amsterdam UMC, University of Amsterdam, Amsterdam, Netherlands.
Lancet Healthy Longev. 2024 Jun;5(6):e431-e442. doi: 10.1016/S2666-7568(24)00068-0. Epub 2024 May 16.
The expected increase of dementia prevalence in the coming decades will mainly be in low-income and middle-income countries and in people with low socioeconomic status in high-income countries. This study aims to reduce dementia risk factors in underserved populations at high-risk using a coach-supported mobile health (mHealth) intervention.
This open-label, blinded endpoint, hybrid effectiveness-implementation randomised controlled trial (RCT) investigated whether a coach-supported mHealth intervention can reduce dementia risk in people aged 55-75 years of low socioeconomic status in the UK or from the general population in China with at least two dementia risk factors. The primary effectiveness outcome was change in cardiovascular risk factors, ageing, and incidence of dementia (CAIDE) risk score from baseline to after 12-18 months of intervention. Implementation outcomes were coverage, adoption, sustainability, appropriateness, acceptability, fidelity, feasibility, and costs assessed using a mixed-methods approach. All participants with complete data on the primary outcome, without imputation of missing outcomes were included in the analysis (intention-to-treat principle). This trial is registered with ISRCTN, ISRCTN15986016, and is completed.
Between Jan 15, 2021, and April 18, 2023, 1488 people (601 male and 887 female) were randomly assigned (734 to intervention and 754 to control), with 1229 (83%) of 1488 available for analysis of the primary effectiveness outcome. After a mean follow-up of 16 months (SD 2·5), the mean CAIDE score improved 0·16 points in the intervention group versus 0·01 in the control group (mean difference -0·16, 95% CI -0·29 to -0·03). 1533 (10%) invited individuals responded; of the intervention participants, 593 (81%) of 734 adopted the intervention and 367 (50%) of 734 continued active participation throughout the study. Perceived appropriateness (85%), acceptability (81%), and fidelity (79%) were good, with fair overall feasibility (53% of intervention participants and 58% of coaches), at low cost. No differences in adverse events between study arms were found.
A coach-supported mHealth intervention is modestly effective in reducing dementia risk factors in those with low socioeconomic status in the UK and any socioeconomic status in China. Implementation is challenging in these populations, but those reached actively participated. Whether this intervention will result in less cognitive decline and dementia requires a larger RCT with long follow-up.
EU Horizon 2020 Research and Innovation Programme and the National Key R&D Programmes of China.
For the Mandarin translation of the abstract see Supplementary Materials section.
在未来几十年,痴呆症的预期发病率将主要出现在低收入和中等收入国家,以及高收入国家中社会经济地位较低的人群中。本研究旨在通过教练支持的移动健康(mHealth)干预措施,减少服务不足的高危人群中的痴呆症风险因素。
这是一项开放标签、盲终点、混合有效性-实施随机对照试验(RCT),旨在研究在英国,社会经济地位较低的 55-75 岁人群,或在中国,来自一般人群、至少有两个痴呆症风险因素的人群中,教练支持的 mHealth 干预措施是否可以降低痴呆症风险。主要有效性结果是心血管风险因素、衰老和痴呆症(CAIDE)风险评分的变化,从基线到干预后 12-18 个月。采用混合方法评估实施结果,包括覆盖率、采用率、可持续性、适宜性、可接受性、保真度、可行性和成本。所有主要结局数据完整、无缺失结局的参与者均纳入分析(意向治疗原则)。该试验在 ISRCTN、ISRCTN15986016 注册,并已完成。
2021 年 1 月 15 日至 2023 年 4 月 18 日,共有 1488 人(601 名男性和 887 名女性)被随机分配(干预组 734 人,对照组 754 人),其中 1229 人(83%)完成了主要有效性结局的分析。平均随访 16 个月(SD 2.5)后,干预组 CAIDE 评分平均改善 0.16 分,对照组平均改善 0.01 分(平均差异-0.16,95%CI -0.29 至 -0.03)。共邀请了 1533 人(10%)作出回应;在干预组中,734 名参与者中有 593 名(81%)采用了干预措施,734 名参与者中有 367 名(50%)在整个研究过程中持续积极参与。感知适宜性(85%)、可接受性(81%)和保真度(79%)良好,整体可行性(干预组为 53%,教练组为 58%)适中,成本低。未发现研究组之间的不良事件存在差异。
在英国社会经济地位较低的人群和中国任何社会经济地位的人群中,教练支持的 mHealth 干预措施在降低痴呆症风险因素方面有一定效果。在这些人群中实施具有挑战性,但参与的人群积极参与。这种干预措施是否会导致认知能力下降和痴呆症减少,还需要进一步的长期随访的大型 RCT 来验证。
欧盟地平线 2020 研究与创新计划和中国国家重点研发计划。